These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Tetradecylthioacetic acid inhibits the oxidative modification of low density lipoprotein and 8-hydroxydeoxyguanosine formation in vitro. Muna ZA, Doudin K, Songstad J, Ulvik RJ, Berge RK. Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3255-62. PubMed ID: 9409320 [Abstract] [Full Text] [Related]
4. Ibuprofen protects low density lipoproteins against oxidative modification. Zapolska-Downar D, Zapolska-Downar A, Bukowska H, Gałka H, Naruszewicz M. Life Sci; 1999 Nov; 65(22):2289-303. PubMed ID: 10597884 [Abstract] [Full Text] [Related]
5. Doxazosin treatment and peroxidation of low-density lipoprotein among male hypertensive subjects: in vitro and ex vivo studies. Brude IR, Drevon CA, Viken K, Arnstad JE, Valnes KN, Nenseter MS. Biochem Pharmacol; 1999 Jul 01; 58(1):183-91. PubMed ID: 10403533 [Abstract] [Full Text] [Related]
12. Mangostin inhibits the oxidative modification of human low density lipoprotein. Williams P, Ongsakul M, Proudfoot J, Croft K, Beilin L. Free Radic Res; 1995 Aug 15; 23(2):175-84. PubMed ID: 7581813 [Abstract] [Full Text] [Related]
13. In vitro and ex vivo inhibition of the modification of low-density lipoprotein by indapamide. Breugnot C, Iliou JP, Privat S, Robin F, Vilaine JP, Lenaers A. J Cardiovasc Pharmacol; 1992 Sep 15; 20(3):340-7. PubMed ID: 1279277 [Abstract] [Full Text] [Related]
14. A critical overview of the chemistry of copper-dependent low density lipoprotein oxidation: roles of lipid hydroperoxides, alpha-tocopherol, thiols, and ceruloplasmin. Burkitt MJ. Arch Biochem Biophys; 2001 Oct 01; 394(1):117-35. PubMed ID: 11566034 [Abstract] [Full Text] [Related]
15. Thyroid hormone (T3) and its acetic derivative (TA3) protect low-density lipoproteins from oxidation by different mechanisms. Faure P, Oziol L, Artur Y, Chomard P. Biochimie; 2004 Jun 01; 86(6):411-8. PubMed ID: 15283976 [Abstract] [Full Text] [Related]
17. Iron induces lipid peroxidation in cultured macrophages, increases their ability to oxidatively modify LDL, and affects their secretory properties. Fuhrman B, Oiknine J, Aviram M. Atherosclerosis; 1994 Nov 01; 111(1):65-78. PubMed ID: 7840815 [Abstract] [Full Text] [Related]
18. Resveratrol inhibits copper ion-induced and azo compound-initiated oxidative modification of human low density lipoprotein. Zou JG, Huang YZ, Chen Q, Wei EH, Hsieh TC, Wu JM. Biochem Mol Biol Int; 1999 Jun 01; 47(6):1089-96. PubMed ID: 10410255 [Abstract] [Full Text] [Related]
19. Copper- and magnesium protoporphyrin complexes inhibit oxidative modification of LDL induced by hemin, transition metal ions and tyrosyl radicals. Kapiotis S, Hermann M, Exner M, Laggner H, Gmeiner BM. Free Radic Res; 2005 Nov 01; 39(11):1193-202. PubMed ID: 16298745 [Abstract] [Full Text] [Related]